|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Tel-Aviv Sourasky Medical Center (Drs. Schwarz and Greif), Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel; Thoraxklinik at University of Heidelberg (Dr. Becker), Heidelberg, Germany; Beth-Israel Deaconess Medical Center (Dr. Ernst), Boston, MA; and The Cleveland Clinic Foundation (Dr. Mehta), Cleveland, OH.
Correspondence to: Yehuda Schwarz, MD, Pulmonary Institute, Tel Aviv Sourasky Medical Center, Weizman Stt 6, Tel Aviv 64239, Israel; e-mail: Schwarz{at}tasmc.health.gov.il
Abstract
Study objectives: To characterize the feasibility, accuracy, and safety of the superDimension/Bronchus system (SDBS) [superDimension, Ltd; Hertzliya, Israel] in navigating to previously unreachable peripheral lung lesions and obtaining biopsy specimens.
Design: Open-label, prospective, controlled clinical study.
Setting: Pulmonary institute of a university-affiliated municipal hospital.
Patients: Thirteen adult candidates for nonemergency bronchoscopy who gave informed consent to participate.
Interventions: The patients underwent flexible bronchoscopy using the SDBS, which is based on real-time CT-guided electromagnetic navigation and is capable of reaching peripheral lung masses beyond the reach of the bronchoscope. A position sensor was used to navigate to and sample the various target lesions for biopsy.
Measurements and results: Three-dimensional chest CT was followed by SDBS methodology for marking anatomic landmarks and the target lesion on a virtual bronchoscopy screen and for sampling the lesion. The SDBS assisted in obtaining positive biopsy diagnoses in 9 of 13 cases (69%), with an average navigation accuracy of 5.7 mm. There were no SDBS-related adverse events.
Conclusions: The SDBS is safe and effective in navigating to peripheral lung lesions located beyond the optic limits of a standard flexible bronchoscope.
Key Words: navigation bronchoscopy peripheral lesion
The flexible bronchoscope is used primarily to examine anatomic and pathologic structures inside the airways or to reach various lung lesions and acquire tissue samples for diagnosis. The instrument is also used to treat central airway obstructions by removing or cauterizing them with a laser. Standard flexible bronchoscopes, however, cannot reach most lung target lesions; more than two thirds of these masses are located at peripheral locations not accessible to the bronchoscope due to its diameter relative to the constantly narrowing branches of the bronchial tree.12 In a retrospective analysis, Hoffmann and Dienemann3 showed that almost 50% of the sampled lesions were benign. Radke et al4 reported that the number of benign lesions detected in screening programs exceeded 90%. Insofar as benign nodules do not require surgical resection, the ability to obtain specimens of isolated peripheral lung lesions via bronchoscopic technology could obviate the complications of more invasive biopsy procedures and inevitably reduce the number of unnecessary surgeries by ruling out malignancy.
The final and most critical stages of the advance of a bronchoscope through the bronchial tree to the lesion are performed in an essentially "blind" manner. The bronchoscope usually becomes wedged at a segment of the tree, and the endoscopic tools, such as diagnostic brushes or forceps, are pushed out toward the targeted lung area, guided by fluoroscopy. The fluoroscopic images, however, can neither provide depth perception nor can they depict the intricate anatomy of the bronchial tree. Determining lung opacity is also often problematic with standard bronchoscopic evaluations. These shortcomings establish the need for a tool that can provide navigational information with real-time positioning of the tip of the forceps as a guide to help the bronchoscopist grasp an endobronchially invisible peripheral lesion. Such a tool would facilitate diagnosis and obviate further interventional diagnostic procedures when that lesion is confirmed as being benign.
One of new technologies that allows an approach to the peripheral lung masses is electromagnetic navigation based on virtual bronchoscopy and real-time three-dimensional (3D) CT images. This technology was incorporated in the superDimension/Bronchus system (superDimension; Hertzliya, Israel) and has been shown to be capable of reaching peripheral lung masses beyond the reach of the standard bronchoscope in an animal model.5 The aim of the current study was to determine the feasibility, accuracy, and safety of the SDBS to navigate to peripheral lung lesions in humans and to examine its capability of increasing the diagnostic yield of the transbronchial biopsies (TBBs) in those patients.
Materials and Methods
Fifteen subjects (7 men and 8 women; age range, 26 to 81 years) were originally enrolled into an open-label, prospective, single-group, controlled clinical study from June 2003 to May 2004. The study was approved by the Tel Aviv Sourasky Medical Center Helsinki Committee, and informed consent was obtained from all the subjects prior to bronchoscopy. Bronchoscopy was performed on an outpatient basis under conscious sedation with midazolam or propofol. Patient selection was based on nonendoscopically visible lesions, regardless of the lesion size or lobe location, since the main objective of this study was to evaluate the feasibility of the SDBS to visualize these masses.
Electromagnetic Navigation System
The electromagnetic navigation system is an image-guided localization device that assists the endobronchial accessories (forceps, brush, needle) in reaching the desired areas of the lung. A detailed description of this system has appears in an earlier publication.5
Electromagnetic Location Board: The system uses low-frequency electromagnetic waves that are emitted from a 1-cm-thick, 47 x 56-cm electromagnetic board that is placed under the cephalad end of the mattress of the bronchoscopy table (Fig 1 ).
|
|
|
Radiologic Mapping (Planning): The digitized information from the CT scan was downloaded into the SDBS software in digital imaging and communications in medicine format. This information was then used to reconstruct axial, coronal, and sagittal views of the chest and virtual images of the bronchial tree. Between five and seven anatomic landmarks were marked as coordinates on the corresponding CT as well as on the virtual bronchoscopy image. In addition, the target lesion was identified and marked at its center in a similar fashion (Fig 4 ).
|
|
Results
The SDBS navigation procedure was performed in 13 of the 15 originally enrolled subjects. One subject was dropped after severe bronchoconstriction developed as a result of propofol sedation, and the other subject was dropped for poor virtual bronchoscopy findings due to excessive mucopurulent secretions in the bronchial airways. Data from both subjects were excluded from the analyses.
The size of lesions was from 1.5 to 5 cm (average, 3.35 ± 1.1 cm) [Table 1 ]. The location of the lesions was as follows: four lesions were located at the left upper lobe (LUL), three at the right upper lobe (RUL), five at the right lower lobe (RLL), and one at the right middle lobe (RML). All lesions were displayed on the chest CT and were beyond the reach of a standard bronchoscope as required in the current study protocol. Average duration of the intervention was 46 min (range, 25 to 68 min).
|
Two of the lesions were located behind the blood vessels, and one lesion was surrounded by granulomatous tissue, making the navigation process very difficult in these patients. No biopsy tool reached the lesion in one patient, probably due to the technical problems, and this patient subsequently underwent CT-guided FNA.
No device-related adverse events were reported during or up to 48 h after the study. The accuracy of the navigation process, as expressed by the average of fiducial as target registration error value, was 5.7 mm.
Discussion
In the present study, we were able to show a high diagnostic yield using SDBS navigation for diagnosing peripheral pulmonary lesions. The diagnostic sensitivity of this procedure was as high as 69% in peripheral pulmonary lesions beyond the optical reach of the bronchoscope compared to the diagnostic sensitivity of flexible fiberoptic bronchoscopy (FFB) for small peripheral pulmonary lesions under radiographic fluoroscopic guidance, which has been < 35% in our institute. Moreover, the feasibility of the steerable system of the locatable guide enabled us to advance through the intricate bronchial tree by executing more turns and bends until the targeted lesion had been reached. The use of the EWC facilitates several attempts at introducing the forceps directly up to the lesion area. Should the EWC be dislodged, it is easy to repeat the navigation process and continue in the effort to grasp tissue for diagnosis.
The current success rate in diagnostic bronchoscopies for peripheral lesions is very low.4678 The accuracy of diagnosing peripheral pulmonary lesions from retrieved tissue samples using transbronchial biopsy (TBB) is reportedly 20 to 84% in cases of malignant lesions, and 35 to 56% in cases of benign lesions. The yield of TBB is even lower in small lesions.9101112131415 Thus, Baaklini et al9 reported that lesions
2.0 cm in diameter had a diagnostic yield of 14% when located in the peripheral third, compared with 31% when located in the inner two thirds of the lung. The patients in whom the diagnostic bronchoscopy has failed are usually referred to more invasive procedures, such as CT-guided percutaneous biopsies or a surgical biopsy, both associated with much higher costs and greater risk for the patient.16171819 Moreover, the great majority of patients who are candidates for investigation of peripheral lesions have some degree of emphysematous changes and poor pulmonary function, putting them at increased risk of pneumothorax by percutaneous techniques.
The need to accurately reach peripheral lung locations via bronchoscopy has been documented in numerous scientific articles and is a prevailing topic at most pulmonology conferences.20212223 Reports on sporadic attempts to resolve this need continue to appear in the literature.2425 CT-guided TBB or cytology was developed to overcome the problem of incorrect positioning of the forceps or curette.26 An ultrathin bronchoscope was developed that can be inserted into more peripheral bronchi than conventional bronchoscopes under direct vision.2728293031 Recently, the working channel of an ultrathin bronchoscope has become wider, extending the possibility for the collection of peripheral tissue specimens. In addition, rapid progress in computer technology has resulted in advances in diagnostic imaging. Virtual bronchoscopy is the application of 3D display techniques to the airways, enabling the simulation of actual bronchoscopic procedures.527
The current study results show that the SDBS can be effectively used as an aid in guiding other tools to peripheral lung lesions. The system was now also shown to be safe during the procedures in humans as it had been in animal trials.5
The lesions targeted in this study were all beyond the optical range of routine bronchoscopic procedures. Such lesions are usually sampled by more invasive techniques, such as CT-guided FNA or surgery, approaches that involve higher risks and costs; for example, there is a 20% (13 to 25%) risk of pneumothorax in patients undergoing FNA.3233 The results of our current and earlier studies5 indicate that the new technology could help to establish diagnosis in peripheral lung lesions as an extension of standard FFB without resorting to these techniques and with high success rates. An accurate diagnosis by TBB may obviate unnecessary surgery under general anesthesia for the diagnosis of benign nodules. Importantly, even video-assisted thoracoscopic biopsy bears considerable risk for elderly patients or patients with poor respiratory or cardiac function.
Other problems in diagnosing small peripheral pulmonary lesions that are invisible under fluoroscopic radiograph guidance are related to the difficulty in maneuvering within the angles of the bronchial tree and in identifying accessible bronchial branches for reaching the lesion. If there were navigational information with real-time position of the tip of the forceps as a guide to help the bronchoscopist to grasp peripheral lesion (invisible endobronchially), a diagnosis could be reached easily and further interventional diagnostic procedures could be prevented.
It should be emphasized that in addition to all the above-mentioned limitations, small peripheral lung opacities are being increasingly observed due to the growing popularity of CT scans (6.7 million CT scans in the United States in 2001) and also to the popular shift to filtered cigarettes, which is believed to increase the relative proportion of peripheral (vs central) lung lesions, with the smaller, filtered particles being considered to penetrate deeper within the bronchial tree.34 Considering the fact that both cancer and emphysema are directly related to smoking, the importance of diagnosing small peripheral pulmonary lesions goes without saying. Despite spectacular medical advances in the last 50 years, lung cancer causes more deaths than any other cancer in both men and women. It is now the most common form of cancer diagnosed in the United States and a major cause of death, accounting for 14% of all cancers and 31% all cancer deaths in males.35
The ability of the SDBS to reach peripheral lesions with a high success rate is probably due to two factors. The first is the use of a "road map" that reduces trial-and-error effects in the navigation of tools in the airways. The second is the innovative locatable guide, which is steerable. This allows active manipulation of the tool inside the airways, facilitating navigation through difficult curves, such as the upper lobes of the lungs. We believe that this technology has much potential in increasing the diagnostic yield of FFB for peripheral lung lesions.
In conclusion, SBDS appears to be an effective and safe tool in the diagnosis of peripheral lung lesion beyond standard endoscopic vision, avoiding the need to refer patients for more risky procedures when the biopsy identifies a benign lesion. The SBDS can greatly improve the diagnostic accuracy of a standard FFB and obviate the need for more invasive measures.
Footnotes
Abbreviations: 3D = three dimensional; EWC = extended working channel; FFB = flexible fiberoptic bronchoscopy; FNA = fine-needle aspiration; LUL = left upper lobe; NSCLC = non-small cell lung carcinoma; RML = right middle lobe; RLL = right lower lobe; RUL = right upper lobe; SDBS = superDimension/Bronchus system; TBB = transbronchial biopsy
Grant support was provided by superDimension, Ltd, Hertzliya, Israel.
Received for publication August 23, 2005. Accepted for publication October 19, 2005.
References
tefanec, T, Brown, K, et al Role of fine-needle aspirates of focal lung lesions in patients with hematologic malignancies. Chest 2002;121,527-532This article has been cited by other articles:
![]() |
S. A. Merritt, J. D. Gibbs, K.-C. Yu, V. Patel, L. Rai, D. C. Cornish, R. Bascom, and W. E. Higgins Image-Guided Bronchoscopy for Peripheral Lung Lesions: A Phantom Study Chest, November 1, 2008; 134(5): 1017 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Kuo, S.-M. Lin, H.-C. Chen, C.-L. Chou, C.-T. Yu, and H.-P. Kuo Diagnosis of Peripheral Lung Cancer With Three Echoic Features Via Endobronchial Ultrasound Chest, September 1, 2007; 132(3): 922 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Anantham, D. Feller-Kopman, L. N. Shanmugham, S. M. Berman, M. M. DeCamp, S. P. Gangadharan, R. Eberhardt, F. Herth, and A. Ernst Electromagnetic Navigation Bronchoscopy-Guided Fiducial Placement for Robotic Stereotactic Radiosurgery of Lung Tumors: A Feasibility Study Chest, September 1, 2007; 132(3): 930 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Eberhardt, D. Anantham, F. Herth, D. Feller-Kopman, and A. Ernst Electromagnetic Navigation Diagnostic Bronchoscopy in Peripheral Lung Lesions Chest, June 1, 2007; 131(6): 1800 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Gildea, P. J. Mazzone, D. Karnak, M. Meziane, and A. C. Mehta Electromagnetic Navigation Diagnostic Bronchoscopy: A Prospective Study Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 982 - 989. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |